CN108624680B - Rae1基因或蛋白作为诊断心肌梗死的生物标志物的应用 - Google Patents
Rae1基因或蛋白作为诊断心肌梗死的生物标志物的应用 Download PDFInfo
- Publication number
- CN108624680B CN108624680B CN201810715884.7A CN201810715884A CN108624680B CN 108624680 B CN108624680 B CN 108624680B CN 201810715884 A CN201810715884 A CN 201810715884A CN 108624680 B CN108624680 B CN 108624680B
- Authority
- CN
- China
- Prior art keywords
- rae1
- gene
- myocardial infarction
- chip
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Microbiology (AREA)
- Pathology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (10)
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810715884.7A CN108624680B (zh) | 2018-07-03 | 2018-07-03 | Rae1基因或蛋白作为诊断心肌梗死的生物标志物的应用 |
PCT/CN2019/094268 WO2020007270A1 (zh) | 2018-07-03 | 2019-07-01 | 无创诊断心肌梗死的标志物和诊断方法 |
US17/247,534 US11718880B2 (en) | 2018-07-03 | 2020-12-15 | Marker and diagnosis method for noninvasive diagnosis of myocardial infarction |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810715884.7A CN108624680B (zh) | 2018-07-03 | 2018-07-03 | Rae1基因或蛋白作为诊断心肌梗死的生物标志物的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108624680A CN108624680A (zh) | 2018-10-09 |
CN108624680B true CN108624680B (zh) | 2019-09-10 |
Family
ID=63688597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810715884.7A Active CN108624680B (zh) | 2018-07-03 | 2018-07-03 | Rae1基因或蛋白作为诊断心肌梗死的生物标志物的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108624680B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020007270A1 (zh) * | 2018-07-03 | 2020-01-09 | 北京泱深生物信息技术有限公司 | 无创诊断心肌梗死的标志物和诊断方法 |
CN112760372A (zh) * | 2021-03-23 | 2021-05-07 | 山东第一医科大学第二附属医院 | 心肌梗死差异表达基因及其应用 |
-
2018
- 2018-07-03 CN CN201810715884.7A patent/CN108624680B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN108624680A (zh) | 2018-10-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6615681B2 (ja) | 臓器移植患者における移植片拒絶反応の非侵襲的診断方法 | |
KR101211280B1 (ko) | 신규한 뇌손상 질환 진단용 마커 및 이의 용도 | |
EP2904118B1 (en) | Urine exosome mrnas and methods of using same to detect diabetic nephropathy | |
CN105603101B (zh) | 检测8个miRNA表达量的系统在制备诊断或辅助诊断肝细胞癌产品中的应用 | |
WO2015069933A1 (en) | Circulating cell-free dna for diagnosis of transplant rejection | |
US10266895B2 (en) | Exosomes and microvesicles in intestinal luminal fluids and stool and use of same for the assessment of inflammatory bowel disease | |
CN108796069A (zh) | 心肌梗死的诊断标志物-ing1基因 | |
CN111826466A (zh) | 乙型肝炎感染患者或携带者外泌体miRNA分子标志物组合及筛查试剂盒 | |
CN108624680B (zh) | Rae1基因或蛋白作为诊断心肌梗死的生物标志物的应用 | |
CN105349641B (zh) | 急性心肌梗死相关基因serpinb13及其应用 | |
CN108796067B (zh) | 血液中maea基因的诊断新功能 | |
CN105567862B (zh) | Cdk18在制备诊断冠心病产品中的用途 | |
CN108753956A (zh) | Kdsr基因在制备心肌梗死诊断工具中的应用 | |
CN108753957A (zh) | 诊断心肌梗死的ivd基因及其应用 | |
CN108796068A (zh) | 用于早期诊断心肌梗死的dock10基因 | |
CN105177171A (zh) | Akr1b10在制备急性心肌梗死诊疗制剂中的应用 | |
CA3232274A1 (en) | Drain fluid for diagnostics | |
CN108034714A (zh) | Arhgap26基因在制备帕金森诊断工具中的应用 | |
CN108048554A (zh) | Thbd基因作为帕金森症诊断的分子标志物 | |
CN107475376A (zh) | 预测小细胞肺癌对化疗药物敏感性的标记物及试剂盒 | |
EP4036233A1 (en) | Method for detecting brain tumor | |
WO2020007270A1 (zh) | 无创诊断心肌梗死的标志物和诊断方法 | |
CN110988346A (zh) | 一种辅助诊断肺癌的标记物以及检测方法 | |
CN110229891A (zh) | 无创诊断男性骨质疏松症的产品 | |
CN109371129A (zh) | hsa_circRNA_0000798作为肝癌早期诊断或预后评估生物标记物的应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: Room 1210, Building 3, Ronghua Xintai Building, 10 Ronghua South Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Applicant after: Beijing Yang Shen biology information technology company limited Address before: 100080 Beijing city Haidian District Shanyuan Street No. 1 cubic court building room 3103 Applicant before: Beijing Yang Shen biology information technology company limited |
|
CB02 | Change of applicant information | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191220 Address after: Room 2503, Qianshan building, building D2, Qingdao International Innovation Park Phase II, No. 1, Keyuan Weiyi Road, Laoshan District, Qingdao, Shandong Province Patentee after: Qingdao Yangshen biomedical Co., Ltd Address before: Room 1210, Building 3, Ronghua Xintai Building, 10 Ronghua South Road, Yizhuang Economic and Technological Development Zone, Daxing District, Beijing Patentee before: Beijing Yang Shen biology information technology company limited |
|
TR01 | Transfer of patent right |